Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

NANot yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Familial Adenomatous Polyposis
Interventions
PROCEDURE

Endurance Exercise Therapy

"* Exercise: Endurance exercise therapy comprising treadmill walking administered by exercise physiologists via a study-kit which includes a smart-watch (activity tracker), heart rate monitor, blood pressure cuff, body composition scale, and etablet)~* Exercise escalation trial testing 3 exercise levels (150, 225, and 300 minutes per week), with one de-escalation exercise of 90 minutes per week, if required.~* The phase 1b trial will evaluate the highest feasible exercise level and one exercise below identified in the phase 1a study."

Trial Locations (3)

10065

Memorial Sloan Kettering Cancer Center, New York

44195

Cleveland Clinic Foundation, Cleveland

48109

University of Michigan Rogel Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan Rogel Cancer Center

OTHER

NCT06641310 - Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP) | Biotech Hunter | Biotech Hunter